{"title": "Using gene silencing to alleviate common ataxia", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/gene_therapy.xml", "value": "Using gene silencing to alleviate common ataxia"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2018/06/180620125943.htm"}], "link": "https://www.sciencedaily.com/releases/2018/06/180620125943.htm", "summary": "In what researchers are calling a game changer for future ataxia treatments, a new study showed the ability to turn down the disease progression of the most common dominantly inherited ataxia, Spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/gene_therapy.xml", "value": "In what researchers are calling a game changer for future ataxia treatments, a new study showed the ability to turn down the disease progression of the most common dominantly inherited ataxia, Spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease."}, "published": "Wed, 20 Jun 2018 12:59:43 EDT", "published_parsed": [2018, 6, 20, 16, 59, 43, 2, 171, 0], "id": "https://www.sciencedaily.com/releases/2018/06/180620125943.htm", "guidislink": false}